[The use of beta-interferon-1b in children and adolescents with multiple sclerosis]

Autor:	Olga Bykova, Lm, Kuzenkova, Oi, Maslova
Předmět:	Male Depressive Disorder Multiple Sclerosis Adjuvants Immunologic Adolescent Humans Female Interferon-beta Child Interferon beta-1b
Zdroj:	Europe PubMed Central
Popis:	The use of beta-interferons for immunomodulating treatment of multiple sclerosis (MS) in children is rstudied. We present results of the prospective study of 22 children, aged 13-17 years, with MS treated with beta-interferon-1b (betaferon) during 2-15 (mean 10,72) months. High efficacy and good tolerability of beta-interferon-1b is demonstrated.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fbb3ba9c66f465f9951a5ea9cb80d362 http://europepmc.org/abstract/med/17069059 Zobrazit plný text záznamu